🤍 Donate
People

Katelin Van Deynze

  • This person was identified as:
  • Lobbyist (2023-2025)
  • Advocate (2017-2018, 2023-2025)

Latest Activity

Past Affiliations

Year:

Known Roles

  • Advocate

Known Affiliations

Lobbying Representations

This list shows when this lobbyist testified in a hearing, who they were representing and which bill was involved. The data covers 2015-18 and 2023-present.
DateOrganizationBillHearingTestimony
July 16, 2025Health Access CaliforniaAB 554HealthTestimony Link
July 9, 2025Health Access CaliforniaAB 1418HealthTestimony Link
July 1, 2025Health Access CaliforniaSB 660HealthTestimony Link
April 30, 2025Health Access CaliforniaSB 660HealthTestimony Link
April 29, 2025Health Access CaliforniaAB 1312HealthTestimony Link
April 29, 2025Health Access CaliforniaAB 554HealthTestimony Link
March 3, 2025Health Access CaliforniaBudget No. 1 on HealthTestimony Link
June 26, 2024Health Access CaliforniaAB 236HealthTestimony Link
June 25, 2024Health Access CaliforniaSB 1061HealthTestimony Link
June 25, 2024Health Access CaliforniaSB 966HealthTestimony Link
Showing 1-10 of 23 rows

Testimony

Session:
Preview image for AB 55410MIN
Jul 16, 2025

AB 554

Health care coverage: antiretroviral drugs, drug devices, and drug products.

Preview image for SB 4128MIN
Jul 15, 2025

SB 41

Pharmacy benefits.

Preview image for AB 28022MIN
Jul 9, 2025

AB 280

Health care coverage: provider directories.

Preview image for AB 14188MIN
Jul 9, 2025

AB 1418

Department of Health Care Access and Information.

Preview image for SB 66014MIN
Jul 1, 2025

SB 660

California Health and Human Services Data Exchange Framework.

Preview image for AB 78740MIN
Jun 18, 2025

AB 787

Provider directory disclosures.

Preview image for AB 14154MIN
May 7, 2025

AB 1415

California Health Care Quality and Affordability Act.

Preview image for SB 66012MIN
Apr 30, 2025

SB 660

California Health and Human Services Data Exchange Framework.

Preview image for AB 55412MIN
Apr 29, 2025

AB 554

Health care coverage: antiretroviral drugs, drug devices, and drug products.

Showing 1-9 of 15 testimonies